RCKT (Rocket Pharmaceuticals) FCF Yield %: -42.88 (As of Jul. 04, 2026)

What is Rocket Pharmaceuticals FCF Yield %?

Rocket Pharmaceuticals RCKT +9.25% 30 FCF Yield % is -42.88 as of Jul. 04, 2026. GuruFocus rates RCKT with a GF Score™ of 30/100. The stock has 3 warning signs investors should review. Among 1,413 Biotechnology companies, Rocket Pharmaceuticals ranks worse than 81.53% on this metric.

FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

As of today, Rocket Pharmaceuticals's Trailing 12-Month Free Cash Flow is $-179.79 Mil, and Market Cap is $419.30 Mil. Therefore, Rocket Pharmaceuticals's FCF Yield % for today is -42.88%.

The historical rank and industry rank for Rocket Pharmaceuticals's FCF Yield % or its related term are showing as below:

RCKT' s FCF Yield % Range Over the Past 10 Years
Min: -42.88 Med: 0 Max: 0
Current: -42.88

RCKT's FCF Yield % is ranked worse than
81.53% of 1413 companies
in the Biotechnology industry
Industry Median: -9.25 vs RCKT: -42.88

Rocket Pharmaceuticals's FCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

Rocket Pharmaceuticals FCF Yield % Explanation

Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.

Rocket Pharmaceuticals FCF Yield % Related Terms

Rocket Pharmaceuticals FCF Yield % Historical Data

* Premium members only.

The historical data trend for Rocket Pharmaceuticals's FCF Yield % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Rocket Pharmaceuticals FCF Yield % Chart

Rocket Pharmaceuticals Annual Data

Trend

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

Dec25

FCF Yield %

Get a 7-Day Free Trial

-9.15

-12.06

-7.81

-16.11

-50.09

Rocket Pharmaceuticals Quarterly Data
	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25	Jun25	Sep25	Dec25	Mar26
FCF Yield %	Get a 7-Day Free Trial															-31.55	-74.17	-57.11	-36.74	-46.57

RCKT vs TENX, DMAC, AVIR: FCF Yield % Comparison

For the Biotechnology subindustry, Rocket Pharmaceuticals's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Rocket Pharmaceuticals FCF Yield % vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Rocket Pharmaceuticals's FCF Yield % distribution charts can be found below:

* The bar in red indicates where Rocket Pharmaceuticals's FCF Yield % falls into.

Save Embed

30GF Score

Rocket Pharmaceuticals Inc RCKT

FCF Yield % is just one metric. See GF Score™, valuation, warning signs, and more.

View Full Analysis

Rocket Pharmaceuticals FCF Yield % Calculation

FCF Yield % is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.

Rocket Pharmaceuticals's FCF Yield % for the fiscal year that ended in Dec. 2025 is calculated as

FCF Yield %	=	Free Cash Flow	/	Market Cap
	=	-190.454	/	380.2032
	=	-50.09%

Rocket Pharmaceuticals's annualized FCF Yield % for the quarter that ended in Mar. 2026 is calculated as

FCF Yield %	=	Free Cash Flow	*	Annualized Factor	/	Market Cap
	=	-45.487	*	4	/	390.66392
	=	-46.57%

Frequently Asked Questions Learn more about FCF Yield % →

What does a FCF Yield % of -42.88 mean?

Rocket Pharmaceuticals (RCKT) has a FCF Yield % of -42.88 as of Jul. 04, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Rocket Pharmaceuticals and its competitors. According to the industry distribution chart, Rocket Pharmaceuticals ranks #1152 out of 1413 companies in the Biotechnology industry, placing it in the top 81.5%.

Is Rocket Pharmaceuticals' FCF Yield % too high?

Rocket Pharmaceuticals' current FCF Yield % is -42.88. Based on the distribution chart, Rocket Pharmaceuticals ranks #1152 out of 1413 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Rocket Pharmaceuticals has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.

How does Rocket Pharmaceuticals' FCF Yield % compare to TENX and DMAC?

According to the Biotechnology industry distribution chart, Rocket Pharmaceuticals ranks #1152 out of 1413 companies for FCF Yield %. This places Rocket Pharmaceuticals in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.

What is a good FCF Yield % for a Biotechnology company?

A good FCF Yield % depends on the Biotechnology industry context. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.

What does a high FCF Yield % mean?

A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on Rocket Pharmaceuticals and its competitors. Rocket Pharmaceuticals's current FCF Yield % is -42.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.

Is Rocket Pharmaceuticals stock overvalued right now?

Rocket Pharmaceuticals (RCKT) has a current FCF Yield % of -42.88. The current FCF Yield % is -42.88. Rocket Pharmaceuticals' overall GF Score™ is 30/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.

How is FCF Yield % calculated?

FCF Yield % is calculated from a company's financial statements. For Rocket Pharmaceuticals (RCKT), the current FCF Yield % is -42.88 as of Jul. 04, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Rocket Pharmaceuticals Business Description

Industry Healthcare Biotechnology

Comparable Companies TENX DMAC AVIR VNDA OABI PRLD UPB CYDY LXEO PROK VRTX REGN XBRU:UCB XBRU:ARGX XKRX:207940 ALNY ASX:CSL RVMD ONC MRNA

Other Exchanges 9IP1:Germany

Address 9 Cedarbrook Drive, Cranbury, NJ, USA, 08512

Website https://www.rocketpharma.com

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. It has one reportable segment related to R&D and commercial readiness of its gene therapies.

30GF Score

Get the complete analysis for RCKT

FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$3.84

Price

View RCKT Analysis

See FCF Yield % data for all stocks →